Amgen, GSK Urge Justices To Allow Patents On Genus Claims
Amgen, GlaxoSmithKline and a group of intellectual property professors have urged the U.S. Supreme Court to take up Merck & Co.'s petition asking the justices to ensure companies can patent genus...To view the full article, register now.
Already a subscriber? Click here to view full article